企業プロフィール
Foghorn Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- FHTX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
6.74 USD (+7.67%)
終値
最終更新: 2026年8月17日
213M USD
時価総額
株価変動の要因
As of Aug 17, 2026, FHTX closed up 7.67% at $6.74. No new same-company headline was identified in the current news window.
企業概要
事業概要
Foghorn Therapeutics is an oncology company focused on chromatin biology and gene-regulation targets. Its platform seeks to create differentiated cancer therapies through epigenetic control.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Foghorn sits in specialty oncology biotechnology.
ビジネスモデルの特徴
The company depends on translational data, target validation, and the possibility of building a new oncology platform.
バイオ業界での位置付け
Foghorn is a high-catalyst oncology name with strong dependence on early data quality.
今後のカタリスト
- Foghorn’s next three months are about its chromatin-regulation oncology programs and any data that show the platform can still produce differentiated human results. The market will care most about whether the synthetic-lethality thesis can keep moving forward.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。